Affordable Access

Publisher Website

Identification of a novel missense mutation in Brazilian patient with a severe form of mucopolysaccharidosis type IVA

Publication Date
DOI: 10.1016/j.gene.2012.12.100
  • Morquio A
  • N-Acetylgalactosamine-6-Sulfatase
  • Molecular Analysis
  • Biology
  • Computer Science
  • Medicine


Abstract Mucopolysaccharidosis type IVA (MPS IVA) or Morquio syndrome type A is an autosomal recessive disease caused by deficiency of the lysosomal enzyme N-acetylgalactosamine-6-sulfatase (GALNS). We report molecular characterization of a patient who presents the new missense mutation p.C165Y in homozygosis. Bioinformatics analysis predicted this mutation as being probably pathogenic. To evaluate the possibility that this alteration was a polymorphism we tested 100 alleles and all the results were negative. These findings together with the observation that this alteration is not present in controls, suggest that it is a disease-causing mutation, which was correlated with the severe phenotype observed in our patient. We conclude that molecular analysis of the GALNS gene, in addition to enzyme assays, is important for diagnosis and contributes to the better understanding of the relationship between genotype and phenotype, which is important as enzyme replacement therapy (ERT) will soon become available and treatment decisions will have to be take in such cases.

There are no comments yet on this publication. Be the first to share your thoughts.